Home

By acquiring early US Food and Drug Administration (FDA) feedback through the pre-submission process, the TORUS-2 study (The PQ Bypass pivOtal IDE intra-aRterial stent graft study for occlUsive and re-Stenotic fem-pop revascularisation) is the company’s second IDE approved in less than two years and is the first pivotal IDE for an SFA stent graft since Viabahn received initial PMA approval in 2005.

The TORUS-2 IDE approval comes close on the heels of the approval for the DETOUR-2 trial. Having been exposed to the TORUS stent graft in the context of the DETOUR procedure, increasing demand is being vocalised to get this same stent graft studied for its safety and efficacy within the SFA as an intra-arterial stent graft.

“We have developed a robust technology, which is currently being studied in our DETOUR-2 percutaneous bypass IDE,” said Heather Simonsen, senior vice president and general manager of PQ Bypass. “Now we are expanding our focus to also address SFA lesions earlier in the disease process to target a market that currently has only one entry.”

PAD, left under- or untreated, can deteriorate the body’s vascular system to the point of rest pain, amputation, and even death. Current therapies, such as balloon angioplasty, atherectomy, and bare metal stents, frequently do not provide satisfactory long-term patency and will often require cyclical re-treatment. Stent grafts, unlike bare metal stents, aid in halting the progression of PAD, rather than solely treating the symptoms and allowing the disease to advance.

“This is an incredible win, on the part of every member of the PQ Bypass family,” continues Rich Ferrari, CEO and chairman of the board. “It really speaks to the quality of the work we have done as a company, both internally and in our clinical trials, as well as the TORUS stent graft itself. All of us at PQ are excited about running two pivotal IDE studies that are aiming to provide treatment for such a large and under-served population.”

The company will begin enrolling in the prospective, single-arm, global multicentre study in Q4 of 2019. The study has been approved to enrol up to 188 subjects at up to 40 sites. The TORUS stent graft received CE mark as a part of the DETOUR procedure in 2017.

The TORUS stent graft is limited by federal law to investigational use only and is not available for sale in the USA.

Source VascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua google bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua twitter bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua MySpace bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua LinkedIn bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua stumbleupon bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua icio bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua digg bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Chia sẽ qua yahoo bài: TORUS SFA stent graft pivotal study granted unconditional IDE approval

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.